Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function

Journal of Mammary Gland Biology and Neoplasia

Volumn 8, Issue 3, 2003, Pages 269-285

  Gass, Sandra ^a   Harris, Jessica ^b   Ormandy, Chris ^b   Brisken, Cathrin ^a,c  

^a National Center of Competence in Research in Molecular Oncology   (Switzerland)

^b ST VINCENT S HOSPITAL   (Australia)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Expression arrays; Mammary gland; Nb2 cells; Ovary; Prolactin target genes; Prostate; Uterus

Indexed keywords

JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN KINASE B; STAT5 PROTEIN;

CARCINOGENESIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENE TARGETING; GENETIC SCREENING; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; LYMPHOMA CELL; MALE; MAMMARY GLAND; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY; PROSTATE; RECEPTOR BINDING; REVIEW; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UTERUS; VALIDATION PROCESS;

ANIMALS; GENE EXPRESSION PROFILING; GENITALIA; HUMANS; MAMMARY GLANDS, HUMAN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROLACTIN; TRANSCRIPTION, GENETIC;

EID: 4344640166     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOMG.0000010029.85796.63     Document Type: Review

References (79)

1. P. Franchimont, C. Dourcy, J. J. Legros, A. Reuter, Y. Vrindts-Gevaert, and J. R. Van Cauwenberge (1976). Prolactin levels during the menstrual cycle. Clin. Endocrinol. (Oxf). 5:643-650.
2. N. D. Horseman (2001). Prolactin. In L. J. DeGroot and J. L. Jameson (eds.), Endocrinology, 4th ed. Vol. 1, Philadelphia. Saunders, pp. 209-220.
3. L. A. Manzon (2002). The role of prolactin in fish osmoregulation: A review. Gen. Comp. Endocrinol. 125:291-310.
4. DeVlaming. (1979). Actions of prolactin among the vertebrates. In E. J. W. Barrington (ed.), Hormones and evolution, Academic Press, New York, pp. 561-642.
5. C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly (1998). Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 19:225-68.
6. J. F. Bazan (1989). A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem. Biophys. Res. Commun. 164:788-95.
7. G. S. Campbell, L. S. Argetsinger, J. N. Ihle, P. A. Kelly, J. A. Rillema, and C. Carter-Su (1994). Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc. Natl. Acad. Sci. U.S.A. 91:5232-5236.
8. J. J. Lebrun, S. Ali, L. Sofer, A. Ullrich, and P. A. Kelly (1994). Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J. Biol. Chem. 269:14021-14026.
9. H. Rui, R. A. Kirken, and W. L. Farrar (1994). Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269:5364-5368.
10. R. Piccoletti, P. Maroni, P. Bendinelli, and A. Bernelli-Zazzera (1994). Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem. J. 303(Pt. 2):429-433.
11. K. A. al-Sakkaf, P. R. Dobson, and B. L. Brown (1996). Activation of phosphatidylinositol 3-kinase by prolactin in Nb2 cells. Biochem. Biophys. Res. Commun. 221:779-784.
12. C. Brisken, S. Kaur, T. Chavarria, N. Binart, R. Sutherland, R. Weinberg, P. A. Kelly, and C. J. Ormandy (1999). Prolactin controls mammary gland development via direct and indirect mechanisms. Dev. Biol. 210:96-106.
13. N. Binart, C. Helloco, C. J. Ormandy, J. Barra, P. Clement-Lacroix, N. Baran, P. A. Kelly (2000). Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration. Endocrinology 141:2691-2697.
14. C. Reynolds, K. Montone, C. Powell, J. Tomaszewski, and C. Clevenger (1997). Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 138:5555-5560.
15. M. J. Naylor, J. A. Lockefeer, N. D. Horseman, and C. J. Ormandy (2003). Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism. Endocrine 20:111-114.
16. C. Clevenger, W. Chang, W. Ngo, T. Pasha, K. Montone, and J. Tomaszewski (1995). Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an antocrine/paracrine loop. Am. J. Pathol. 146:695-705.
17. G. Fuh and J. Wells (1995). Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol. Chem. 270:13133-13137.
18. E. Ginsburg and B. Vonderhaar (1995). Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 55:2591-2595.
19. A. J. Vomachka, S. L. Pratt, J. A. Lockefeer, and N. D. Horseman (2000). Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth. Oncogene 19:1077-1084.
20. C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler (2003). The role of prolactin in mammary carcinoma. Endocr. Rev. 24:1-27.
21. Y. N. Sinha (1995). Structural variants of prolactin: Occurrence and physiological significance. Endocr. Rev. 16:354-369.
22. M. Shirota, D. Banville, S. Ali, C. Jolicoeur, J. M. Boutin, M. Edery, J. Djiane, and P. A. Kelly (1990). Expression of two forms of prolactin receptor in rat ovary and liver. Mol. Endocrinol. 4:1136-1143.
23. C. Brisken, M. Socolovsky, H. F. Lodish, and R. A. Weinberg (2002). The signaling domain of the erythropoeitin receptor rescues prolactin receptor-mutant epithelium. Proc. Natl. Acad. Sci. USA. 99:14241-14245.
24. L. Y. Yu-Lee, J. A. Hrachovy, A. M. Stevens, and L. A. Schwarz (1990). Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol. Cell Biol. 10:3087-3094.
25. T. Ganguly, J. F. Hyde, and M. Vore (1993). Prolactin increases Na+/taurocholate cotransport in isolated hepatocytes from postpartum rats and ovariectomized rats. J. Pharmacol. Exp. Ther. 267:82-87.
26. J. Frasor and G. Gibori (2003). Prolactin regulation of estrogen receptor expression. Trends Endocrinol. Metab. 14:118-123.
27. C. T. Albarracin, T. G. Parmer, W. R. Duan, S. E. Nelson, G. Gibori (1994). Identification of a major prolactin-regulated protein as 20 alpha-hydroxysteroid dehydrogenase: Coordinate regulation of its activity, protein content, and messenger ribonucleic acid expression. Endocrinology 134:2453-2460.
28. F. A. Feltus, B. Groner, and M. H. Melner (1999). Stat5-mediated regulation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene: Activation by prolactin. Mol. Endocrinol. 13:1084-1093.
29. R. Nanbu-Wakao, Y. Fujitani, Y. Masuho, M. Muramatu, and H. Wakao (2000). Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol. Endocrinol. 14:307-316.
30. W. A. Guyette, R. J. Matusik, and J. M. Rosen (1979). Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell 17:1013-1023.
31. L. Hennighausen, C. Westphal, L. Sankaran, and C. W. Pittius (1991). Regulation of expression of genes for milk proteins. Biotechnology 6:65-74.
32. T. G. Burdon, K. A. Maitland, A. J. Clark, R. Wallace, and C. J. Watson (1994). Regulation of the sheep beta-lactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-gamma activation site-related element. Mol. Endocrinol. 8:1528-1536.
33. D. A. Favy, P. Rio, J. C. Maurizis, C. Hizel, Y. J. Bignon, and D. J. Bernard-Gallon (1999). Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines. Biochem. Biophys. Res. Commun. 258:284-291.
34. J. L. Brockman, M. D. Schroeder, and L. A. Schuler (2002). PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Mol. Endocrinol. 16:774-784.
35. M. K. Broadhurst and T. T. Wheeler (2001). The p100 coactivator is present in the nuclei of mammary epithelial cells and its abundance is increased in response to prolactin in culture and in mammary tissue during lactation. J. Endocrinol. 171:329-337.
36. T. Yahata, H. Takedatsu, S. L. Dunwoodie, J. Braganca, T. Swingler, S. L. Withington, J. Hur, K. R. Coser, K. J. Isselbacher, S. Bhattacharya, and T. Shioda (2002). Cloning of mouse Cited4, a member of the CITED family p300/CBP-binding transcriptional coactivators: Induced expression in mammary epithelial cells. Genomics 80:601-613.
37. K. Dillner, J. Kindblom, A. Flores-Morales, S. T. Pang, J. Tornell, H. Wennbo, and G. Norstedt (2002). Molecular characterization of prostate hyperplasia in prolactin-transgenic mice by using cDNA representational difference analysis. Prostate 52:139-149.
38. F. G. Robertson, J. Harris, M. J. Naylor, S. R. Oakes, J. Kindblom, K. Dillner, H. Wennbo, J. Tornell, P. A. Kelly, J. Green, and C. J. Ormandy (2003). Prostate development and carcinogenesis in prolactin receptor knockout mice. Endocrinology 144:3196-3205.
39. M. Hayashi, S. Fujimoto, H. Takano, T. Ushiki, K. Abe, H. Ishikura, M. C. Yoshida, C. Kirchhoff, T. Ishibashi, and M. Kasahara (1996). Characterization of a human glycoprotein with a potential role in sperm-egg fusion: cDNA cloning, immunohistochemical localization, and chromosomal assignment of the gene (AEGL1). Genomics 32:367-374.
40. L. M. Klemme, K. P. Roberts, L. B. Hoffman, K. M. Ensrud, J. E. Siiteri, and D. W. Hamilton (1999). Cloning and characterization of the rat Crisp-1 gene. Gene 240:279-288.
41. K. P. Roberts, L. B. Hoffman, K. M. Ensrud, and D. W. Hamilton (2001). Expression of crisp-1 mRNA splice variants in the rat epididymis, and comparative analysis of the rat and mouse crisp-1 gene regulatory regions. J. Androl. 22:157-163.
42. C. H. Yeung, F. Perez-Sanchez, S. Schroter, C. Kirchhoff, and T. G. Cooper (2001). Changes of the major sperm maturation-associated epididymal protein HE5 (CD52) on human ejaculated spermatozoa during incubation. Mol. Hum. Reprod. 7:617-624.
43. I. A. Lea, P. Sivashanmugam, and M. G. O'Rand (2001). Zonadhesin: Characterization, localization, and zona pellucida binding. Biol. Reprod. 65:1691-1700.
44. A. Lundwall, A. Peter, J. Lovgren, H. Lilja, and J. Malm (1997). Chemical characterization of the predominant proteins secreted by mouse seminal vesicles. Eur. J. Biochem. 249:39-344.
45. C. Romano-Carratelli, C. Bentivoglio, I. Nuzzo, N. Benedetto, E. Buommino, A. Cozzolino, M. Carteni, F. Morelli, M. R. Costanza, B. Metafora, V. Metafora, and S. Metafora (2002). Effect of protein SV-IV on experimental Salmonella enterica, serovar Typhimurium infection in mice. Clin. Diagn. Lab Immunol. 9:115-125.
46. L. Williams, C. McDonald, and S. Higgins (1985). Sequence organisation of rat seminal vesicle F gene: Location of transcriptional start point and sequence comparison with six other androgen-regulated genes. Nucleic Acids Res. 13:659-672.
47. C. Stocco, E. Callegari, and G. Gibori (2001). Opposite effect of prolactin and prostaglandin F(2 alpha) on the expression of luteal genes as revealed by rat cDNA expression array. Endocrinology 142:4158-4161.
48. C. Bole-Feysot, E. Perret, P. Roustan, B. Bouchard, and P. A. Kelly (2000). Analysis of prolactin-modulated gene expression profiles during the NB2 cell cycle using differential screening techniques. Genome Biol. 4: RESEARCH0008.Epub 2000 Oct. 16.
49. C. J. Ormandy, A. Camus, J. Barra, D. Damotte, B. Lucas, H. Buteau, M. Edery, N. Brousse, C. Babinet, N. Binart, and P. A. Kelly (1997). Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11:167-178.
50. N. Baran, P. A. Kelly, and N. Binart (2002). Characterization of a prolactin-regulated gene in reproductive tissues using the prolactin receptor knockout mouse model. Biol. Reprod. 66:1210-1218.
51. Z. Hou, J. P. Bailey, A. J. Vomachka, M. Matsuda, J. A. Lockefeer, and N. D. Horseman (2000). Glycosylation-dependent cell adhesion molecule 1 (GlyCAM 1) is induced by prolactin and suppressed by progesterone in mammary epithelium. Endocrinology 141:4278-4283.
52. M. J. Naylor, E. Ginsburg, T. P. Iismaa, B. K. Vonderhaar, D. Wynick, and C. J. Ormandy (2003). The neuropeptide galanin augments lobuloalveolar development. J. Biol. Chem. 278:29145-29152.
53. S. Nandi (1958). Endocrine control of mammary-gland development in the C3H/He Crgl mouse. J. Natl. Cancer Inst. 21:1039-1063.
54. C. Brisken, A. Ayyannan, C. Nguyen, A. Heineman, F. Reinhardt, J. Tan, S. K. Dey, G. P. Dotto, R. A. Weinberg, and T. Jan (2002). IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev. Cell. 3:877-887.
55. K. B. DeOme, L. J. Faulkin Jr., H. A. Bern, and P. B. Blair (1959). Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H Mice. Cancer Res. 19:511-520.
56. -/-) mice during pregnancy and lactation is epithelial cell autonomous. Dev. Biol. 212:1-11.
57. R. C. Hovey, J. Harris, D. L. Hadsell, A. V. Lee, C. J. Ormandy, and B. K. Vonderhaar (2003). Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol Endocrinol. 17:460-471.
58. A. Howlett and M. Bissell (1993). The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell. Biol. 2:79-89.
59. C. J. Ormandy, M. Naylor, J. Harris, F. Robertson, N. D. Horseman, G. J. Lindeman, J. Visvader, and P. A. Kelly (2003). Investigation of the transcriptional changes underlycing functional defects in the mammary glands of prolactin receptor Knockout mice. Recent. Prog. Horm. Res. 58: 297-323.
60. Z. J. Tu, R. Kollander, and D. T. Kiang (1998). Differential up-regulation of gap junction connexin 26 gene in mammary and uterine tissues: The role of Sp transcription factors. Mol. Endocrinol. 12:1931-1938.
61. D. Locke, N. Perusinghe, T. Newman, H. Jayatilake, W. H. Evans, and P. Monaghan (2000). Developmental expression and assembly of connexins into homomeric and heteromeric gap junction hemichannels in the mouse mammary gland. J. Cell. Physiol. 183:229-237.
62. C. Brisken, A. Heineman, T. Chavarria, B. Elenbaas, J. Tan, S. K. Dey, J. A. McMahon, A. P. McMahon, and R. A. Weinberg (2000). Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes. Dev. 14:650-654.
63. J. M. Bradbury, P. A. Edwards, C. C. Niemeyer, and T. C. Dale (1995). Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev. Biol. 170:553-563.
64. N. J. Kenney, G. H. Smith, K. Rosenberg, M. L. Cutler, and R. B. Dickson (1996). Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differ 7:1769-1781.
65. S. K. Das, I. Chakraborty, B. C. Paria, X. N. Wang, G. Plowman, and S. K. Dey (1995). Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus. Mol. Endocrinol. 9:691-705.
66. S. L. Grimm, T. N. Seagroves, E. B. Kabotyanski, R. C. Hovey, B. K. Vonderhaar, J. P. Lydon, K. Miyoshi, L. Hennighausen, C. J. Ormandy, A. V. Lee, M. A. Stull, T. L. Wood, and J. M. Rosen (2002). Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol. Endocrinol. 16:2675-2691.
67. V. Turk, B. Turk, and D. Turk (2001). Lysosomal cysteine proteases: Facts and opportunities. EMBO 120:4629-4633.
68. A. Adenis, G. Huet, F. Zerimech, B. Hecquet, M. Balduyck, and J. P. Peyrat (1995). Cathepsin B, L, and D activities in colorectal carcinomas: Relationship with clinico-pathological parameters. Cancer Lett. 96:267-275.
69. Y. Kanber, N. R. Demirbag, A. D. Sam, and N. Aydin (2002). Cathepsin D expression in colorectal adenocarcinomas and adenomas. Int. J. Biol. Markers 17:165-168.
70. M. A. Burke, D. Hutter, R. P. Reshamwala, and J. E. Knepper (2003). Cathepsin L plays an active role in involution of the mouse mammary gland. Dev. Dyn. 227:315-322.
71. V. Gerke, and S. E. Moss (2002). Annexins: From structure to function. Physiol. Rev. 82:331-371.
72. H. A. Sikder, M. K. Devlin, S. Dunlap, B. Ryu, and R. M. Alani (2003). Id proteins in cell growth and tumorigenesis. Cancer Cell 3:525-530.
73. J. Hasskarl and K. Munger (2002). Id proteins-tumor markers or oncogenes? Cancer Biol. Ther. 1:91-96.
74. K. Miyoshi, B. Meyer, P. Gruss, Y. Cui, J. P. Renou, F. V. Morgan, G. H. Smith, M. Reichenstein, M. Sham, L. Hennighausen, and G. W. Robinson (2002). Mammary epithelial cells are not able to undergo pregnancy-dependent differentiation in the absence of the Helix-Loop-Helix inhibitor Id2. Mol. Endocrinol. 16:2892-2901.
75. A. Mackay, C. Jones, T. Dexter, R. L. Silva, K. Bulmer, A. Jones, P. Simpson, P. A. Harris, P. S. Jat, A. M. Neville, L. F. Reis, S. R. Lakhani, and M. J. O'Hare (2003). cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene 22:2680-2688.
76. M. Taniguchi, K. Miura, H. Iwao, and S. Yamanaka (2001). Quantitativ assessment of DNA microarrays - omparison with Northern blot analyses. Genomics 71:34-39.
77. M. S. Rajeevan, D. G. Ranamukhaarachchi, S. D. Vernon, and E. R. Unger (2001). Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 25:443-451.
78. R. F. Chuaqui, R. F. Bonner, C. J. Best, J. W. Gillespie, M. J. Flaig, S. M. Hewitt, J. L. Phillips, D. B. Krizman, M. A. Tangrea, M. Ahram, and W. M. Linehan (2002). Post-analysis follow-up and validation microarray experiments. Nat. Genet. 32(Suppl):509-514.
79. R. C. Hovey, J. F. Trott, E. Ginsburg, A. Godhar, M. M. Sasaki, S. J. Fountain, K. Sundarajan, B. K. Vonderhaar (2001). Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev. Dyn. 222:192-205.